TABLE 2.
Predicted function and strain(s) | Disrupted gene or gene product | GenBank accession no. | Identity, similarity,a e value | Symbiosisb | Growth in bloodc |
---|---|---|---|---|---|
Surface modification | |||||
JG535 | Glycosyltransferase | YP_727333 | 49, 68, e−86 | 0.0099***/*** | 1.27 |
JG736 | Outer membrane lipoprotein | YP_926710 | 56, 72, e−11 | 0.0031***/** | 0.60 |
JG738 | Methyltransferase type 11 | YP_944741 | 24, 49, e−9 | 0.018***/*** | 1.26 |
Regulatory | |||||
JG574 | rRNA operon | X74684 | 99, 99, e0 | 0.15**/* | 0.61 |
JG697 | GTP-binding protein | YP_857656 | 97, 100, e−70 | 0.092***/— | 0.06 |
JG730 | Response regulator | YP_855452 | 77, 85, e−81 | 0.00020***/** | 2.44 |
JG741 | Exoribonuclease II | YP_855087 | 95, 98, e−76 | 0.28*/* | 0.76 |
Nutritional | |||||
JG537 | Phosphate ABC transporter | YP_270310 | 92, 96, e−10 | 0.033***/* | 0.80 |
JG698 | GufA protein | YP_856244 | 95, 97, e−38 | 0.23*/— | 0.01 |
JG750 | Threonine/serine transporter | NP_755741 | 85, 94, e−168 | 0.10*/** | 1.34 |
Host interaction | |||||
JG752 | ascU | CAD56767 | 100, 100, e−40 | 0.13***/*** | 0.73 |
Unknown | |||||
JG521 | Hypothetical protein | YP_737079 | 33, 54, e−19 | 0.10**/* | 1.19 |
JG523 | No similarity detected | 0.32*/* | 1.07 | ||
JG532 | Conserved hypothetical protein | ZP_01669898 | 53, 69, e−38 | 0.63**/* | 0.36 |
JG533 | KAP family P-loop domain protein | YP_856709 | 71, 80, e−80 | 0.33**/— | 0.60 |
JG538 | Peptidase S15 | ZP_01542412 | 66, 78, e−59 | 0.43*/** | 1.87 |
JG573 | Hypothetical protein | NP_930352 | 52, 70, e−70 | 0.0090***/* | 2.07 |
JG735 | Hypothetical protein | XP_001153743 | 27, 34, e−5 | 0.000076***/** | 0.95 |
JG751 | Hypothetical protein | YP_856595 | 84, 88, e−95 | 0.33*/* | 0.92 |
JG753 | No similarity detected | 0.19**/*** | 1.46 | ||
Wild type | |||||
HM21R | 1.3 | 1.07 |
Percent identity and percent similarity by a BLASTX or BLASTN search.
Mean in vivo CI values. CI values were calculated by dividing the mutant/competitor strain output ratio by the input ratio of the mutant to the competitor. The first set of asterisks after each value represents the results of a two-tailed, one-sided t test that was used to determine whether the CI differed from 1, while the second set of asterisks represents the results of an unpaired two-tailed, two-sided t test that was used to determine whether the in vivo CI differed from the in vitro CI. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; —, not significantly different.
Mean in vitro CI values.